The field of molecular diagnostics provides been searching for a broadly applicable method of standardization to facilitate comparability of data across all labs and platforms, stated Dr. Nick Lazaridis, President of AccuGenomics. Our leading-edge diagnostic solutions in oncology fill up that need. We look forward to making new strides in gene expression examining in 2012. SOURCE AccuGenomics Inc.. AccuGenomics to take part in OneMedForum at Sir Francis Drake hotel AccuGenomics announced today that it will be attending the upcoming OneMedForum in the Sir Francis Drake hotel in San Francisco on January 9-12, coinciding with the JP Morgan Global Health care Conference. AccuGenomics, founded this year 2010, evolves and commercializes standardized gene expression exams that diagnose accurately, guide and monitor cancers treatment.Individuals with a chromosomal rearrangement referred to as the Philadelphia chromosome were not included in the analysis because new medicines have led to a dramatic improvement within their final result. About 13 % of most induction treatment failures involved individuals with the genetic alteration. Related StoriesStudy suggests mix of MMF and CNIs can protect against rare lymphomaShorter sufferers receive lung transplants at lower ratesResearchers hyperlink organ transplant drug to rise in rare lymphoma.
APrON study: Pregnant and lactating women not meeting recommended intake of omega-3 Alberta Being pregnant Outcomes and Diet is a birth cohort involving more than two thousand ladies and their infants from Calgary and Edmonton that was funded by Alberta Innovates Health Solutions and includes experts at the University of Alberta and the University of Calgary.